Nanotechnology and diabetes
DOI:
https://doi.org/10.7439/ijap.v2i4.1408Abstract
Nanotechnology offers sensing technologies that provide more accurate and timely medical information for diagnosing disease, and miniature devices that can administer treatment automatically if required. Some tests such as diabetes blood sugar levels require patients to administer the test themselves to avoid the risk of their blood glucose falling to dangerous levels. Certain users such as children and the elderly may not be able to perform the test properly, timely or without considerable pain. Nanotechnology can now offers new implantable and/or wearable sensing technologies that provide continuous and extremely accurate medical information. In the long run, nanotechnology will clearly open up many routes to treatments and cures for diabetes, as it will for many of the diseases and conditions that currently plague mankind. Nanotechnology offers some new solutions in treating diabetes mellitus. Boxes with nanopores that protect transplanted beta cells from the immune system attack, artificial pancreas and artificial beta cell instead of pancreas transplantation, nanospheres as biodegradable polymeric carriers for oral delivery of insulin are just some of them. The abilities of nanomedicine are huge, and nanotechnology could give medicine an entirely new outlook. Whilst some of these technologies are quite far-fetched, there is evidence that we will see significant advances in the treatment and management of diabetes quite soon. The purpose of this review is to throw more light on the recent advances and impact of nanotechnology on biomedical sciences to cure diabetes.Downloads
Download data is not yet available.
Downloads
Published
2013-08-30
Issue
Section
Review Article
License
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
How to Cite
1.
Nanotechnology and diabetes. Int J Adv Pharm [Internet]. 2013 Aug. 30 [cited 2024 Sep. 8];2(4):40-4. Available from: https://ssjournals.co.in/index.php/ijap/article/view/1408